Search company, investor...
Cubresa company logo

Cubresa

cubresa.com

Founded Year

2011

Stage

Unattributed | Alive

Total Raised

$580K

About Cubresa

Cubresa provides planar gamma and SPECT imaging solutions for the diagnostic, surgical, and pre-clinical imaging marketplace. The company is focused on serving a diverse range of customers, such as hospitals, medical imaging system providers, laboratory system providers, and scientists. Cubresa supplies its products on OEM, Custom, and End Market basis.

Headquarters Location

800 – 136 Market Avenue

Winnipeg, Manitoba, R3B 0P4,

Canada

1-204-272–2409

Missing: Cubresa's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cubresa's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Cubresa Patents

Cubresa has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/14/2013

4/26/2016

Medical imaging, Particle detectors, Medical physics, Sensors, Ionising radiation detectors

Grant

Application Date

2/14/2013

Grant Date

4/26/2016

Title

Related Topics

Medical imaging, Particle detectors, Medical physics, Sensors, Ionising radiation detectors

Status

Grant

Latest Cubresa News

SPECT Scanning Services Market Technological Advancement, Growing Trends and Demand Prospects 2022-2032

Nov 9, 2022

SPECT Scanning Services Market Technological Advancement, Growing Trends and Demand Prospects 2022-2032 The Global SPECT Scanning Services Market is worth US$ 1,950.6 Million in 2022. The SPECT scanning services market is expected to expand at an average CAGR of 7.8% and reach US$ 4,434.8 Million by 2032. Request a Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-4122 Research and development in radiopharmaceuticals, an increase in cancer cases, brain diseases, heart difficulties, and bone disorders, increased public awareness of SPECT and PET in nuclear medicine, and advancements in SPECT equipment are all projected to fuel the SPECT scanning service market expansion. SPECT scanners are one of the most important medical diagnostic equipment. SPECT scanning services are utilized in a wide variety of diagnostic and therapeutic applications. These are also used along with CT scanning services for analyzing human anatomy and physiology. The SPECT scanners consist of radioactive substances and a high-resolution camera to form 3D pictures. These devices are safe to use. The procedure involving SPECT scanner is simple. A radioactive tracer is injected into the blood, which produces gamma rays. The camera captures the image, and this image is presented on the computer. The affected area will appear dark in color. Less tracker would mean the cell in the particular area is dead. 3 Top Drivers Influencing the SPECT Scanning Services Market Increasing Investment in Research and Development: With increasing cases of certain health complications like cancer, brain disorders, heart problems, and bone disorders, the medical community is investing heavily in research and development. In order to analyze the condition of certain body parts during the course of R&D, more and more usage of SPECT scanners is expected. This might increase the demand for SPECT scanning services. Wide Range of Applications: One of the biggest advantages of using SPECT scanners is the wide range of applications they provide. The application further increases if they are used along with MRI and CT scans for better imaging quality and high-resolution images. Accuracy: The SPECT scanners are known to work with a high level of accuracy. The SPEC scanners operate on the basis of nuclear medicine imaging techniques. The ability of nuclear imaging techniques to accurately detect molecular activity in the body and diagnose diseases at their earliest stages is expected to increase the demand for SPECT scanning services. Ask an Analyst @  https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-4122 Challenges Limiting the SPECT Scanning Services Market Half-life of Radioactive substance: The half-life associated with the radioactive substance pose certain threats. The reason being the radioactive elements with half-life can dose the patient very badly, if not handled with proper precautions. High Capital Investment: The price of SPECT scanners are in millions of dollars. This means not all the hospitals can purchase these scanners because of a high initial investment. This might affect the SPECT scanning services adoption trends. Opportunities Ahead for SPECT Scanning Services Market Opportunities: Data Integrating Imaging Systems: By using data-integrated imaging systems, it is possible to process and reconstruct images, identify medical conditions through computer-assisted recognition, create 3D images, and employ quality control measures. Data integration makes it easier for doctors to compare scans and track the disease’s progression. This is expected to change the outlook of SPECT scanning services market. Integration Via Mobile Technologies: There is a huge opportunity to make data accessible via mobile technologies in addition to data integration. Doctors are likely to be able to review and analyze scans from any location. Companies are focusing on developing integrated systems for SPECT scanning because of the advantages and convenience they provide, as well as the huge demand from hospitals. How are the Start-ups influencing the SPECT Scanning Services Market? As per the developments taking place in the start-up space, molecular imaging (MI) technologies are undergoing major changes. Early MI leaders provided clinicians with hybrid imaging technologies that coupled CT localization with SPECT and PET functional information (PET). With solid-state detectors, innovators pushed the limits of medical imaging and helped physicians see diseases in more detail. These new imaging systems provided additional imaging data for processing and advanced automated tools and AI-based reconstruction algorithms to help clinicians make complicated diagnoses. Additionally, patient safety is given a lot of priority in this region. The application of SPECT scanners ensures safety for patients and carries out the required procedure seamlessly. What are the Major Players in the SPECT Scanning Services Market? The global demand for SPECT scanning services is highly fragmented and competitive due to the presence of numerous regional and local companies. Major players use a variety of marketing strategies, including mergers and acquisitions, developments, alliances, and partnerships. Increasing a company’s share of the consumer market also entails developing new products. As a result of these advancements, the effectiveness of SPECT scanning services has increased. Some of the key players are Gamma Medica Inc., GE Healthcare, Siemens Healthineers, Toshiba Medical Systems Corporation, Mediso Medical Imaging Systems Ltd., Digirad Corporation, Positron Corporation, DDD Diagnostics, Cubresa Inc., and others. Recent Developments in the SPECT Scanning Services Market Product Launches: GE Healthcare intends to add two new radiopharmaceuticals to its portfolio in March 2022, one for Positron Emission Tomography (PET) and one for Single-Photon Release Calculated Tomography (SPCT). A PET radiopharmaceutical imaging intermediary was recently declared the first patient enrolled in a Phase III clinical trial, with the goal of assisting in the assessment of adult patients with suspected Parkinsonian syndromes, providing research, and improving patient care. Mergers & Acquisitions: As recently as November 2020, GE Healthcare announced the acquisition of Prismatic Sensors AB, a Swedish start-up that is focused on photon counting CT detectors. Oncology, cardiology, neurology, and numerous other clinical CT claims could benefit greatly from this information. Key Companies Profiled Gamma Medica Inc., GE Healthcare, Siemens Healthineers, Toshiba Medical Systems Corporation, Mediso Medical Imaging Systems Ltd Digirad Corporation, Positron Corporation, DDD Diagnostics, Cubresa Inc. and Others. Key segments

Cubresa Frequently Asked Questions (FAQ)

  • When was Cubresa founded?

    Cubresa was founded in 2011.

  • Where is Cubresa's headquarters?

    Cubresa's headquarters is located at 800 – 136 Market Avenue, Winnipeg.

  • What is Cubresa's latest funding round?

    Cubresa's latest funding round is Unattributed.

  • How much did Cubresa raise?

    Cubresa raised a total of $580K.

  • Who are the investors of Cubresa?

    Investors of Cubresa include Manitoba Knights, Manitoba Technology Accelerator and Research Manitoba.

  • Who are Cubresa's competitors?

    Competitors of Cubresa include SynchroPET.

Compare Cubresa to Competitors

L
Lucerno Dynamics

Lucerno Dynamics manufactures medical technology that helps scan human tissue and organs during medical tests. The company was founded in 2011 and is based in Cary, North Carolina.

SynchroPET Logo
SynchroPET

SynchroPET is developing a next-generation positron emission technology (PET) with multiple applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.